Status:
COMPLETED
Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence
Lead Sponsor:
Eko Devices, Inc.
Conditions:
Left Ventricular Dysfunction
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify peo...
Detailed Description
Heart failure with reduced left ventricular ejection fraction (EF) is a relatively common cardiac pathology with major clinical implications. People with reduced left ventricular EF are at increased r...
Eligibility Criteria
Inclusion
- English-speaking adults who are 18 years and older
- Able and willing to provide informed consent
- Complete a clinical echocardiogram within 7 days before or after study procedures
Exclusion
- Unwilling or unable to provide informed consent
- Patients who are hospitalized
Key Trial Info
Start Date :
July 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 29 2022
Estimated Enrollment :
1258 Patients enrolled
Trial Details
Trial ID
NCT04400435
Start Date
July 15 2020
End Date
April 29 2022
Last Update
December 9 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Alamitos Cardiovascular
Los Alamitos, California, United States, 90720
2
MedStar Cardiovascular Network
Washington D.C., District of Columbia, United States, 20010
3
Albert Einstein Medical Center
Philadelphia, Pennsylvania, United States, 19141